Skip to Content

1122 (Qtern dapagliflozin 10 mg / saxagliptin 5 mg)

Generic Name: dapagliflozin/saxagliptin

Pill with imprint 1122 is Brown, Round and has been identified as Qtern dapagliflozin 10 mg / saxagliptin 5 mg. It is supplied by AstraZeneca Pharmaceuticals LP.

Qtern is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Qtern dapagliflozin 10 mg / saxagliptin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 1122

Qtern

Generic Name:
dapagliflozin/saxagliptin
Imprint:
1122
Strength:
dapagliflozin 10 mg / saxagliptin 5 mg
Color:
Brown
Shape:
Round
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
AstraZeneca Pharmaceuticals LP
National Drug Code (NDC):
00310-6780

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide